GLP-1 prescription meds mimic these hormones to support genetic, biological and environmental factors that may make weight loss more difficult
Reference [1]Balimane P V, Chong S, Morrison R A
We want patients to have access to this medication. Recently, the FDA announced the removal of certain compounded GLP-1 ingredients from its drug shortage list
While they may sound similar and sit in the same broad family of injectable metabolic medications, they are not the same thing
We address GLP-1 side effects actively rather than as an inevitable cost of treatment
Alternatively, some patients transition to oral semaglutide or oral tirzepatide if they haven't previously used that delivery form, as the gastrointestinal absorption kinetics differ slightly and may reset receptor sensitivity